<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-EZCW38LG</identifier><date>2023</date><creator>Devjak, Rok</creator><relation>documents/doc/E/URN_NBN_SI_doc-EZCW38LG_001.pdf</relation><relation>documents/doc/E/URN_NBN_SI_doc-EZCW38LG_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 43-45</format><identifier identifier_type="COBISSID_HOST">141497859</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-EZCW38LG</identifier><language>slv</language><publisher publisher_location="Ljubljana">Katedra za onkologijo</publisher><publisher publisher_location="Ljubljana">Onkološki inštitut</publisher><publisher publisher_location="Ljubljana">Sekcija za internistično onkologijo</publisher><source>Novosti v imunoterapiji 2022</source><rights>InC</rights><subject language_type_id="slv">imunoterapija</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="slv">onkološko zdravljenje</subject><title>Prekinitev zdravljenja in reindukcija zdravljenja z imunskimi kontrolnimi točkami</title><title>Treatment discontinuation and rechallenge of immune checkpoint inhibitors</title></Record>